Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Ambrx Biopharma Inc | AMAM | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 28.00 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 28.00 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 6.55 - 28.15 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 28.00 | USD |
Ambrx Biopharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 1.75B | - | - | - | 66.67 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ambrx Biopharma News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/18/2024 | 13:45 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section.. |
| 3/12/2024 | 15:55 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/10/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 3/08/2024 | 12:39 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in.. |
| 3/07/2024 | 12:23 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration.. |
| 3/07/2024 | 07:49 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/06/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/23/2024 | 13:09 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 2/22/2024 | 07:31 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 2/22/2024 | 07:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/12/2024 | 12:43 | PR Newswire (US) | Kuehn Law Encourages AMAM, DOOR, CBAY, and WISH Investors to.. |
| 1/10/2024 | 14:07 | PR Newswire (US) | Kuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AMAM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 27.78 | 28.03 | 27.51 | 27.89 | 1,545,736 | 0.22 | 0.79% |
| 6 Months | 10.40 | 28.15 | 7.99 | 22.79 | 1,590,654 | 17.60 | 169.23% |
| 1 Year | 9.65 | 28.15 | 6.55 | 18.80 | 1,016,346 | 18.35 | 190.16% |
| 3 Years | 10.74 | 28.15 | 6.55 | 18.22 | 953,178 | 17.26 | 160.71% |
| 5 Years | 10.74 | 28.15 | 6.55 | 18.22 | 953,178 | 17.26 | 160.71% |
Ambrx Biopharma Description
| Ambrx Biopharma Inc is a clinical-stage biologics company focused on discovering and developing a novel class of engineered precision biologics (EPBs) using its proprietary expanded genetic code technology platform that allows incorporating synthetic amino acids (SAAs) into proteins within living cells. Its product pipeline includes ARX788, ARX517, ARX305 among others. |
